Mark A. Travis

5.5k citations
52 papers · 4.5k · 2 hit papers · h-index 31

Impact in

Papers in

    • T-cell and B-cell Immunology 13
    • Immunotherapy and Immune Responses 3
    • IL-33, ST2, and ILC Pathways 2
    • Immune Response and Inflammation 2
    • Cell Adhesion Molecules Research 9

Mark A. Travis

51 papers receiving 4.5k citations

Mark A. Travis's Hit Papers

Therapeutic targets in lung tissue remodelling and fibrosis 2021 · 197 citations
1970+4+8Years since publication200400600

Peers

Mark A. Travis
Comparison fields: 5 of 104
  • Immunology and Allergy 418
  • Immunology 1.4k
  • Parasitology 196
  • Molecular Biology 1.1k
  • Oncology 349
Replace Björn Petri with:
Björn Petri Canada
Mark C. Udey United States
J. Sjef Verbeek Netherlands
Marinus C. Lamers Germany
Ariel Munitz Israel
Kazufumi Matsushita Japan
Paul Eggleton United Kingdom
Niamh E. Mangan Australia
Kensuke Miyake Japan
Gregoire S. Lauvau United States
Mark A. Travis relative to Björn Petri Canada Björn Petri's profile →
Citations per field
00.5×2×3×3.6×
Björn Petri · 1×
Citations per year

Countries citing papers authored by Mark A. Travis

Since Specialization
Citations

This map shows the geographic impact of Mark A. Travis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Travis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Travis more than expected).

Fields of papers citing papers by Mark A. Travis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Travis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Travis. The network helps show where Mark A. Travis may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Travis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Travis Line = papers co-authored together Mark A. Travis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
TGF-β Activation and Function in Immunity
Hit paper breakdown →
2013710
2 2007438
3 2018279
4 2021201
5
Therapeutic targets in lung tissue remodelling and fibrosis
Hit paper breakdown →
2021197
6 2010190
7 2019169
8 2015163
9 2011149
10 2018143
11 2021128
12 2012122
13 2016120
14 2004113
15 2017112
16 2009105
17 2010104
18 2018103
19 2012100
20 200492

About Mark A. Travis

Mark A. Travis is a scholar working on Immunology, Immunology and Allergy, Molecular Biology, Parasitology and Genetics, having authored 52 papers that have together received 4.5k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (13 papers), TGF-β signaling in diseases (11 papers), Cell Adhesion Molecules Research (9 papers), Parasites and Host Interactions (4 papers), Inflammatory Bowel Disease (4 papers), Immunotherapy and Immune Responses (3 papers), IL-33, ST2, and ILC Pathways (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology and Allergy (418 citations), Immunology (1.4k citations), Parasitology (196 citations), Molecular Biology (1.1k citations) and Oncology (349 citations). Mark A. Travis has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Dean Sheppard, John J. Worthington, Joanna E. Klementowicz, Andrew C. Melton, Aoife Kelly, Martin James Humphries, Beata I. Czajkowska, Richard K. Grencis, Thomas M. Fenton and Jeffrey A. Bluestone. Their work appears in journals such as Mucosal Immunology, Nature Communications, Journal of Clinical Investigation, Nature and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact